November 2026 — The rare kidney disease (RKD) community celebrates a huge landmark milestone following the U.S. Food and Drug Administration’s (FDA) approval of GAZYVA® (obinutuzumab) as the first and ... Read more The post The U.S. Food and Drug Administration Approves GAZYVA (obinutuzumab) as the First and Only Treatment for Primary Membranous Nephropathy appeared first on NephCure .
https://nephcure.org/the-u-s-food-and-drug-administration-approves-gazyva-obinutuzumab-as-the-first-and-only-treatment-for-primary-membranous-nephropathy/